Aram Lyu (@AramLyu) profile picture
United States
Joined July 2015
Aram Lyu retweeted
Another great talk from Aram Lyu at PCF!
2
5
245
Meet 2023 Parker Scholar Aram Lyu, PhD @aramlyu @UCSFMedicine. He is using myeloid cells to mediate immunotherapy resistance in prostate cancer that has metastasized. Hear his thoughts on the future of #cancerresearch here: youtube.com/shorts/GwanyfFn8… #PICINetwork
4
9
1,536
Today we announced our 2023 class of Early Career Researcher awardees – 8 exceptional graduate and postdoctoral researchers from leading academic institutions who will share up to $2.9 million for their innovative research #PICINetwork Meet them here: youtu.be/MGxLtPYNaMs
1
2
1
12
2,836
Celebrating the next generation of researchers at the @AACR Annual Meeting! @AndreaMiyahira joined the 2026 recipients of the PCF Scholar-in-Training Awards, recognizing outstanding early-career scientists presenting impactful work in prostate cancer. #AACR26
4
14
1,147
Welcome to the 2026 #SITC #Sparkathon participants (Sparkies). We would like to thank them for participating in this unique program to advance their careers in immuno-oncology! #TCells #IO #SITCQuestfor100
5
3
13
6,401
The 2024 Young Investigator Awards recipients have just been announced. Congrats to this year’s class, who received $6.3 million in funding for innovative prostate cancer research. Meet this year’s class: bit.ly/YIAwardsClass2024 #ProstateCancer #MedEd #MedX
9
2
36
4,655
Aram Lyu retweeted
Aram Lyu, Peiqi Ou, Helen Rizos, and Annette Paschen discuss "Cancer Immune Evasion" in a symposium at the AACR IO Conference on Discovery and Innovation in Cancer Immunology. #AACRIO25 @HelenRizos @AramLyu
3
1
16
1,914
Aram Lyu retweeted
ScRNAseq of prostate cancer samples revealed an SPP1hi TAM population that correlated with progression and T cell exhaustion. bit.ly/3ZPj4Fk  @AramLyu  @parkerici  @lawfong
2
7
547
Fred Hutch researchers shared new research at the @sitcancer meeting in early Nov. Findings included new strategies to avoid T-cell exhaustion in CAR T cells & insights into how solid tumors change microenvironment to blunt the immune system’s response. bit.ly/4gbmvwI
2
8
824
Why has immunotherapy, transformative for some cancers, struggled in prostate cancer? A new @Nature study, led by @lawfong (former PICI Co-Director at @UCSF, now at @fredhutch) with 1st author Aram Lyu, PhD (PICI Investigator, UCSF), uncovers key insights. 1/3
2
14
44
7,703